Chevret S, Roquin H, Ganne P, Lefrère J J
Département de Biostatistique et Informatique Médicale, Hôpital Saint-Louis, Paris, France.
AIDS. 1992 Nov;6(11):1349-52. doi: 10.1097/00002030-199211000-00018.
To evaluate the prognostic value of an elevated CD8 lymphocyte count in the early stages of HIV infection.
A prospective study ongoing since January 1986.
One hundred and fifty-two asymptomatic HIV-positive individuals with a CD4 lymphocyte count > 400 x 10(6)/l at enrollment were included. Disease progression was defined as a CD4 count < 200 x 10(6)/l.
During the follow-up period, CD4 count decreased in 33 individuals; CD8 count increased to > 1500 x 10(6)/l in 38 individuals and doubled in 35. The risk of a decreasing CD4 count was estimated to be 1.7-fold higher, although not significantly so, after the elevation of the CD8 count to > 1500 x 10(6)/l than before or in the absence of such an increase. However, this predictive value disappeared when five baseline parameters found to predict the outcome (neopterin, beta 2-microglobulin, p24 antigen, anti-p18 antibody and immunoglobulin A) were adjusted.
Elevated CD8 count appears to be a weak marker for disease progression.
评估HIV感染早期CD8淋巴细胞计数升高的预后价值。
自1986年1月起开展的一项前瞻性研究。
纳入152例无症状HIV阳性个体,入组时CD4淋巴细胞计数>400×10⁶/l。疾病进展定义为CD4计数<200×10⁶/l。
在随访期间,33例个体的CD4计数下降;38例个体的CD8计数升至>1500×10⁶/l,35例个体的CD8计数翻倍。CD8计数升至>1500×10⁶/l后,CD4计数下降的风险估计比之前或未出现此类升高时高1.7倍,尽管差异无统计学意义。然而,当对发现可预测结果的五个基线参数(新蝶呤、β2-微球蛋白、p24抗原、抗p18抗体和免疫球蛋白A)进行调整后,这种预测价值消失。
CD8计数升高似乎是疾病进展的一个弱标志物。